Peter Hanson

Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA.

The American Veterinary Medical Association (AVMA) is an organization that represents over 95,000 members and works to protect, promote, and advance the needs of all veterinarians and those they serve. The AVMA is based in Schaumburg, IL, and Janet Donlin has been the CEO of the private company since 2016. The AVMA provides a variety of resources and tools to help veterinarians run a more efficient and successful practice, including practical tools for day-to-day operations, HR management, and business calculators. The organization also partners with state veterinary associations to advocate for animal health, animal welfare, and the advancement of the veterinary profession.

Merial, Inc. develops pharmaceutical products and vaccines for pets and wildlife. It provides healthcare products and food for dogs, cats, cattle, horse, and poultry producers. The company was founded in August 1997 and is headquartered in Duluth, GA.

Part of Zoetis, Inc., Abbott Animal Health, Inc. develops animal vaccines and prescription medicines. The company is based in Abbott Park, IL. Abbott Animal Health was acquired by Zoetis, Inc. from Abbott Laboratories on February 10, 2015 for $255 million.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.